Safely Prescribing Nirmatrelvir and Ritonavir-Avoiding Drug-Drug Interactions.

Culas, Roshni; Nath, Sridesh; Nath, Sarath

Culas, Roshni; Nath, Sridesh; Nath, Sarath.

Afiliación

Culas R; Division of Infectious Disease, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Nath S; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Nath S; Division of Infectious Diseases, Department of Medicine, Stony Brook University Hospital, Stony Brook, New York.

JAMA Intern Med ; 183(4): 362-363, 2023 04 01.

Article en En | MEDLINE | ID: mdl-36807493

This Teachable Moment discusses drug-drug interactions with nirmatrelvir and ritonavir (Paxlovid) treatment for COVID-19 and considerations when prescribing.

Asunto(s)

Lactamas; Ritonavir; Humanos; Ritonavir/uso terapéutico; Nitrilos; Antivirales

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ritonavir / Lactamas Límite: Humans Idioma: En Revista: JAMA Intern Med Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google